Table 3 Vaccination target-specific averted influenza-related events, in EU-8 countries (France, Italy, Spain, UK, Poland, Slovakia, Sweden and Germany) using efficacy values at current VCR
From: Annual public health and economic benefits of seasonal influenza vaccination: a European estimate
Influenza-related events averted | 6 – 23 months | Elderly | Chronically ill | Healthcare workers | Pregnant women | Totals |
|---|---|---|---|---|---|---|
cases (%) | 55,626 (3.3) | 1,178,452 (70.0) | 418,050 (24.8) | 21,046 (1.2) | 11,026 (0.7) | 1,684,200 |
GP visits (%) | 17,585 (2.4) | 423,686 (57.1) | 280,906 (37.9) | 13,342 (1.8) | 6,604 (0.9) | 742,123 |
Hospitalizations (%) | 333 (0.6) | 50,706 (92.5) | 3,704 (6.8) | 60 (0.1) | 29 (0.1) | 54,832 |
Deaths (%) | 3 (0.0) | 30,238 (97.7) | 705 (2.3) | 0 | 0 | 30,946 |
Days of work lost (%) | 9,492 (1.6) | 0 | 558,516 (92.0) | 26,713 (4.4) | 12,650 (2.1) | 607,371 |